Asia Pacific Bioprocessing Facilities


Featuring key Bioprocessing Facilities from China, Taiwan, Korea, Japan, India, SEA, and Australia! Asia-Pacific Bioprocessing Facilities report covers comprehensive information on parameters such as facility sizecapacityproduction technologiestypes of biologics manufactured and much more. It provides readers a closer look into the facilities of ChugaiHanmiDaiichi SankyoBiocon (India & SEA), BeigeneAmgen (Singapore)GSK (Singapore) and more.

  • Insights on production processes various BioPharmas currently and plan to employ.
  • Understand the facility expansion plans of key players in the industry.
  • Identify potential clients who would be interested in your latest technology or service.
  • The report also features checklists based on DesignFlex30 and highlights examples of companies that have constructed their facilities in a flexible manner catering to the fast-changing needs of the industry.